DocSym
β
Searchsearch
Search
(Y51.4) Predominantly alpha-adrenoreceptor agonists, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis predominantly alpha-adrenoreceptor agonists, not elsewhere classified confirmed
507 deaths with diagnosis predominantly alpha-adrenoreceptor agonists, not elsewhere classified
3% mortality rate associated with the disease predominantly alpha-adrenoreceptor agonists, not elsewhere classified
Diagnosis predominantly alpha-adrenoreceptor agonists, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis predominantly alpha-adrenoreceptor agonists, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis predominantly alpha-adrenoreceptor agonists, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease predominantly alpha-adrenoreceptor agonists, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features predominantly alpha-adrenoreceptor agonists, not elsewhere classified
Absence or low individual and public risk
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified - what does this mean
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified, are a group of drugs that act on alpha-adrenergic receptors in the body to produce various effects. these drugs work by stimulating the alpha-adrenergic receptors, which in turn causes the body to produce certain hormones and neurotransmitters that can affect the body in various ways such as increasing blood pressure, decreasing heart rate, and constricting blood vessels.
What happens during the disease - predominantly alpha-adrenoreceptor agonists, not elsewhere classified
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified is a disease caused by an overstimulation of alpha-adrenoreceptors in the body. this overstimulation leads to an increase in the production of hormones such as epinephrine and norepinephrine, which can cause an array of symptoms such as an increased heart rate, increased blood pressure, anxiety, and sweating. if left untreated, this can lead to an increased risk of cardiovascular complications such as heart attack and stroke.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination to assess signs and symptoms of the disease
- Laboratory tests including blood tests, urine tests, and imaging studies
- Endocrine testing such as hormone levels
- Genetic testing to identify any underlying genetic causes
- Neuropsychological testing to assess cognitive functioning
- Psychological evaluation to assess mood and behavior
- Medication review to identify any medications that may be contributing to the condition
Treatment and Medical Assistance
Main goal of the treatment: To reduce symptoms of the disease by targeting predominantly alpha-adrenoreceptor agonists.
- Prescribing medications that act as alpha-adrenoreceptor agonists
- Using lifestyle modifications to reduce symptoms
- Monitoring patient’s progress and adjusting treatment accordingly
- Educating the patient on the disease and its treatment
- Providing support and resources to the patient
- Referring the patient to a specialist if necessary
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Predominantly alpha-adrenoreceptor agonists, not elsewhere classified - Prevention
The best way to prevent predominantly alpha-adrenoreceptor agonists, not elsewhere classified is to practice healthy lifestyle habits, such as eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, it is important to be aware of any underlying medical conditions that may increase the risk of developing this condition, and to seek medical attention if any symptoms arise.